SUPERFICIAL INFLAMMATORY DERMATOSIS

SUPERFICIAL INFLAMMATORY DERMATOSIS was reported 123 times

These drug classes are most commonly taken by patients reporting SUPERFICIAL INFLAMMATORY DERMATOSIS:

# Drug Count
0 Corticosteroid [EPC] 17
1 Kinase Inhibitor [EPC] 13
2 Tumor Necrosis Factor Blocker [EPC] 11
3 Nonsteroidal Anti-inflammatory Drug [EPC] 10
4 Vitamin C [EPC] 8
5 Folate Analog Metabolic Inhibitor [EPC] 7
6 Microtubule Inhibitor [EPC] 7
7 Interleukin-4 Receptor alpha Antagonist [EPC] 5
8 Platelet Aggregation Inhibitor [EPC] 5
9 Vitamin B12 [EPC] 5
10 Vitamin D [EPC] 5
11 Benzodiazepine [EPC] 4
12 Calcineurin Inhibitor Immunosuppressant [EPC] 4
13 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 4
14 Loop Diuretic [EPC] 4
15 Nitrofuran Antibacterial [EPC] 4
16 Proton Pump Inhibitor [EPC] 4
17 Alkylating Drug [EPC] 3
18 Anthelmintic [EPC] 3
19 Aromatase Inhibitor [EPC] 3
20 Azole Antifungal [EPC] 3
21 CD20-directed Cytolytic Antibody [EPC] 3
22 Estrogen Receptor Antagonist [EPC] 3
23 Janus Kinase Inhibitor [EPC] 3
24 Osmotic Laxative [EPC] 3
25 Penem Antibacterial [EPC] 3
26 RANK Ligand Inhibitor [EPC] 3
27 Retinoid [EPC] 3
28 Xanthine Oxidase Inhibitor [EPC] 3
29 Aminoglycoside Antibacterial [EPC] 2
30 Anti-IgE [EPC] 2
31 Anti-epileptic Agent [EPC] 2
32 Antimetabolite [EPC] 2
33 Calcium Channel Blocker [EPC] 2
34 Catecholamine [EPC] 2
35 Dietary Cholesterol Absorption Inhibitor [EPC] 2
36 Dihydropyridine Calcium Channel Blocker [EPC] 2
37 HMG-CoA Reductase Inhibitor [EPC] 2
38 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 2
39 Histamine-1 Receptor Antagonist [EPC] 2
40 Interleukin-17 Receptor A Antagonist [EPC] 2
41 Mood Stabilizer [EPC] 2
42 P2Y12 Platelet Inhibitor [EPC] 2
43 Platinum-based Drug [EPC] 2
44 Thalidomide Analog [EPC] 2
45 alpha-Adrenergic Agonist [EPC] 2
46 beta-Adrenergic Agonist [EPC] 2
47 Aldosterone Antagonist [EPC] 1
48 Amide Local Anesthetic [EPC] 1
49 Antiarrhythmic [EPC] 1
50 Antimycobacterial [EPC] 1
51 Antirheumatic Agent [EPC] 1
52 Atypical Antipsychotic [EPC] 1
53 CD30-directed Immunoconjugate [EPC] 1
54 Complement Inhibitor [EPC] 1
55 Dipeptidyl Peptidase 4 Inhibitor [EPC] 1
56 Ester Local Anesthetic [EPC] 1
57 Factor Xa Inhibitor [EPC] 1
58 Glycopeptide Antibacterial [EPC] 1
59 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1
60 Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1
61 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1
62 Histamine-2 Receptor Antagonist [EPC] 1
63 Human Immunoglobulin G [EPC] 1
64 Nitroimidazole Antimicrobial [EPC] 1
65 Non-Standardized Chemical Allergen [EPC] 1
66 Non-Standardized Food Allergenic Extract [EPC] 1
67 Non-Standardized Plant Allergenic Extract [EPC] 1
68 Noncompetitive AMPA Glutamate Receptor Antagonist [EPC] 1
69 Nucleoside Metabolic Inhibitor [EPC] 1
70 Phosphodiesterase 4 Inhibitor [EPC] 1
71 Potassium Salt [EPC] 1
72 Programmed Death Ligand-1 Blocker [EPC] 1
73 Proteasome Inhibitor [EPC] 1
74 Purine Antimetabolite [EPC] 1
75 RNA Synthetase Inhibitor Antibacterial [EPC] 1
76 Rifamycin Antibacterial [EPC] 1
77 Selective T Cell Costimulation Modulator [EPC] 1
78 Serotonin Reuptake Inhibitor [EPC] 1
79 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 1
80 Sulfonylurea [EPC] 1
81 Tetracycline-class Drug [EPC] 1
82 Thiazide Diuretic [EPC] 1
83 Typical Antipsychotic [EPC] 1
84 alpha-Adrenergic Blocker [EPC] 1
85 beta-Adrenergic Blocker [EPC] 1
86 mTOR Inhibitor Immunosuppressant [EPC] 1